Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

Megaround for gene therapy play Neurogene
Neurogene Inc. raised $115 million in a series B round led by EcoR1 Capital, with participation by existing